InMed Pharmaceuticals, Inc.

Ordinary Shares International Reporting
Verified Company Profile 7/21/2016
Contact Info
  • 350-409 Granville Street
  • Vancouver, BC V6C1T2
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001429816
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Eric Adams President
Terese Gieselman CFO
Sazzad Hossain Chief Scientific Officer
Company Directors
Chris Bogart
Adam Cutler
William Garner
Sazzad Hossain
Andrew Hull
Craig Schneider
Company Notes
  • Formerly=Cannabis Technologies Inc. until 10-2014
  • Formerly=Meridex Software Corp. until 5-2014
  • Formerly=Meridex Network Corp. until 2-03
Service Providers
Accounting/Auditing Firm Legal Counsel
Stella Business Law Services
3691 West King Edward Avenue
Vancouver, BC, V6S 1M8

Investor Relations Firm
Not Available
IMLFF Security Details
Share Structure
Market Value1 $10,232,059 a/o Dec 09, 2016
Authorized Shares Unlimited a/o Oct 25, 2016
Outstanding Shares 93,018,717 a/o Nov 28, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Shareholders of Record 112 a/o Oct 25, 2016
Non US Stock Exchange Listing
IN - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 55,318 (329.55%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security